Ledger.Open graph →

SEC Form D · filed December 20, 2011

Presidio Pharmaceuticals, Inc

Offering

$13.0M

Sold

$6.0M

Exemption

—

Industry

Pharmaceuticals

Location

SAN FRANCISCO, CA

Type

—

People & firms on this filing (16)

Kenneth Galbraith · San Francisco, CAExec · Director Srinivas Akkaraju · San Francisco, CADirector John F. Obijeski · San Francisco, CADirector Rodney Ferguson · San Francisco, CADirector Felix Baker · San Francisco, CADirector H. Daniel Perez · San Francisco, CAExec · Director Leo Redmond · San Francisco, CAExec · Director John G. Barrie · EDINBURGH, SCOTLAND, United KingdomExec · Director George W. Browning · EDINBURGH, SCOTLAND, United KingdomExec · Director Alan W. Paterson · EDINBURGH, SCOTLAND, United KingdomDirector Edward H. Hocknell · EDINBURGH, SCOTLAND, United KingdomDirector Dickson H. Jackson · EDINBURGH, SCOTLAND, United KingdomDirector Ron Hunt · East Providence, RIDirector Joshua M. Braunfeld · New York, NYExec · Director Rich Colonno · San Francisco, CAExec Nat Brown · San Francisco, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗